ArrayExpress Gene Expression Atlas home | about the project | faq | feedback | blog | das | api new | help
PPP1R3D Homo sapiens
PPP1R3D is differentially expressed in 103 experiments [102 up/113 dn]: 24 organism parts: peripheral blood [2 up/0 dn], white blood cells [0 up/1 dn], ...; 28 disease states: normal [3 up/6 dn], Huntington's disease [2 up/0 dn], ...; 19 cell types, 28 cell lines, 28 compound treatments and 21 other conditions.
Synonyms PPP1R3D, PPP1R6
Orthologs CC8.2 (Caenorhabditis elegans)  LOC682185 (Rattus norvegicus)  CG9619 (Drosophila melanogaster)  Ppp1r3d (Mus musculus)  zgc:174896 (Danio rerio)  (Compare orthologs)
InterPro Term Protein phosphatase 1, glycogen targeting subunit, Metazoa, Putative phosphatase regulatory subunit
GO Terms glycogen metabolic process, protein binding, protein serine/threonine phosphatase activity
Uniprot O95685  Q86X09 
Search EB-eye ENSG00000132825
REST API
Expression Summary
191 factor values, click each to filter
Factor Value Factor Up/Down
Legend: - number of studies the gene is up/down in
Normal Disease state
6
3
None Compound treatment
4
1
FLAP Compound treatment
2
MK886 Compound treatment
2
MCF-7 Cell line
2
BT-474 Cell line
2
Fibroblast Cell type
1
1
Peripheral blood Organism part
2
Huntington's disease Disease state
2
HNRPA2B Compound treatment
2
SW480 Cell line
1
1
SW620 Cell line
1
1
Primary Disease staging
1
1
Male Sex
1
1
MCF7 Cell line
1
Bacterial endotoxin Compound treatment
1
Control Compound treatment
1
Breast carcinoma Disease state
1
Glucocorticoid resistant Phenotype
1
White blood cells Organism part
1
SKMEL5 Cell line
1
CodeLink Labeling Protocol type
1
Not applicable Histology
1
N/a Test result
1
Acute promyelocytic leukemia Disease state
1
U937 Cell line
1
Invasive ductal carcinoma Histology
1
Pretreatment primary sample Clinical info
1
SsMCF7 Cell line
1
PC3 Cell line
1
0 cm away from the tumor bound... Observation
1
Stage II Disease staging
1
HPL1 Cell line
1
Fu97 Cell line
1
ERalpha transfected Genotype
1
ERbeta transfected Genotype
1
Mannitol Compound treatment
1
Affymetrix Labeling Protocol type
1
Methotrexate Compound treatment
1
AZ521 Cell line
1
Cerebellum Organism part
1
Tumor Organism part
1
MDA-MB-231 Cell line
1
In vitro neutrophil Cell type
1
Hypericin incubated, not irrad... Growth condition
1
Hypericin incubated, irradiate... Growth condition
1
Superficial transitional cell ... Disease state
1
Alveolar space neutrophil Cell type
1
Vanadium pentoxide Compound treatment
1
Lipopolysaccharide Compound treatment
1
Iloprost Compound treatment
1
SKBR3 Cell line
1
Childhood acute myeloid leukem... Disease state
1
Glucocorticoid sensitive Phenotype
1
Trichostatin A Compound treatment
1
Poorly differentiated gastric ... Disease state
1
Endothelial cell Cell type
1
Enzo Labeling Protocol type
1
Potassium dichromate Compound treatment
1
MDA468 Cell line
1
Epidermal growth factor Compound treatment
1
Rapamycin Compound treatment
1
Gastric cancer Disease state
1
Organism_part Material type
1
Cell Material type
1
Epilepsy Disease state
1
Atrial mycocardium Organism part
1
Ventricular myocardium Organism part
1
Superior cervical ganglion Organism part
1
Smooth muscle Organism part
1
Training set Population
1
Test set Population
1
X-linked chronic granulomatous Disease state
1
T47-D Cell line
1
Lymphoid tissue Organism part
1
Bone marrow Organism part
1
5-aza-2'-deoxycytidine Compound treatment
1
Sevoflurane Compound treatment
1
T-cell lymphoblastic lymphoma Disease state
1
Kaposi's sarcoma Disease state
1
Placebo Compound treatment
1
Glutamine Compound treatment
1
Johnsen score count 2: Sertoli... Histology
1
Trigeminal ganglion Organism part
1
Teratozoospermia Disease state
1
Normospermic Disease state
1
Oligodendroglioma Disease state
1
Control Clinical info
1
Hydrogen peroxide Compound treatment
1
T84 Cell line
1
Caco-2 Cell line
1
Synovial fluid Organism part
1
Monocyte at intermediate diffe... Cell type
1
M1 macrophage Cell type
1
Chronic lymphocytic leukemia Disease state
1
DMSO Vehicle
1
HeLa Cell line
1
18/22 Genotype
1
T4aN0M0 Disease staging
1
IgV status unknown Genotype
1
Endometrioid carcinoma Disease state
1
SkinEthic keratinocyte Cell type
1
Epidermal keratinocyte Cell type
1
Psoriatic lesional biopsy Clinical info
1
Uninvolved biopsy Clinical info
1
Idiopathic dilated cardiomyopa... Disease state
1
Heregulin Compound treatment
1
Unknown_sex Sex
1
MKN74 Cell line
1
Epithelial cell Cell type
1
Stromal cell Cell type
1
Term Developmental stage
1
Midgestation Developmental stage
1
Ethanol Vehicle
1
T47D Cell line
1
Liver Organism part
1
Benign nevi Disease state
1
Interferon-gamma + lipopolysac... Compound treatment
1
Cigarette smoke Growth condition
1
Incubator control Growth condition
1
Cancer6 Replicate
1
Grade IV Tumor grading
1
Granulocyte-colony stimulating... Compound treatment
1
Stage I Disease staging
1
Glioblastoma Disease state
1
Frontal cortex, primary motor ... Organism part
1
CD34+ Cell type
1
Lymph node metastasis Disease staging
1
Cigarette smoke Compound treatment
1
CD71+ early erythroid Cell type
1
Stage IV/2 Disease staging
1
Tissue culture polystyrene dis... Growth condition
1
Collagen/chondroitin tissue en... Growth condition
1
HTERT/HPVE6/HPVE7/SV40t transf... Gene modification
1
Dimethyl sulfoxide Compound treatment
1
17-allylamino-geldanamycin Compound treatment
1
Down syndrome Disease state
1
MCF10A Cell line
1
ITM-ST Cell line
1
Hematopoietic stem cell Cell type
1
Adipose tissue-derived stem ce... Cell type
1
Mesenchymal stem cell Cell type
1
HMEC184 Cell line
1
Fetal thyroid Organism part
1
Multiple myeloma Disease state
1
Lymph node Organism part
1
Tonsil Organism part
1
None Infection
1
Carcinoma in situ lesion Disease state
1
Wild_type Genotype
1
PML/RAR Genotype
1
A549 Cell line
1
Clear cell sarcoma of the kidn... Disease state
1
Kidney Organism part
1
Monocyte Cell type
1
Beta cell islets Organism part
1
Cystic change Histology
1
ITV Cell line
1
Carboplatin resistant Test result
1
Carboplatin sensitive Test result
1
Heat-killed HL60 cell lysate Infection
1
Homo sapiens Organism
1
Pan troglodytes Organism
1
Diagnosed with skin cancer bef... Clinical history
1
Ulcerative colitis Disease state
1
Skeletal muscle Organism part
1
None Gene modification
1
Estrogen receptor 1 positive; ... Test result
1
Baseline sevoflurane Compound treatment
1
T1bN0M0 Disease staging
1
Cervical cancer Disease state
1
Ovary Organism part
1
IgV unmutated Genotype
1
Well-functioning transplant Clinical info
1
Uterine cervix Organism part
1
Prostate Organism part
1
BCKN-1 Cell line
1
M-CSF Compound treatment
1
Small cell lung carcinoma Disease state
1
Endothelial cell + pericyte Cell type
1
Johnsen score count 10: full s... Histology
1
Female Sex
1
LEDGF knockdown RNAi
1
Control RNAi
1
Keratinocyte Cell type
1
Limited radiation toxicity Clinical history
1
Muscle invasive carcinoma Disease state
1
CD3+ CD4+ CD8- CD45RA+ CD62L+ Phenotype
1
Naive T cell Cell type
1
Pancreas Organism part
1
YCC16 Cell line
1
Expression Profiles
E-MEXP-1014: Transcription profiling of two human colon cancer cell lines treated with n-3 PUFA docosahexaenoic acid for 3 different time points
Experimental Factors
Show expression profile  /  experiment details

 
E-GEOD-5258: Transcription profiling of human cell lines freely cycling treated with 164 distinct small molecules - Broad Connectivity Map CMAP Set 1
Experimental Factors
Show expression profile  /  experiment details

 
E-GEOD-4646: Transcription profiling of human HUVEC cells infected with Neisseria meningitidis wild type and mutants vs uninfected sampled at 3 time points
Experimental Factors
Time Infection
Show expression profile  /  experiment details

 
E-GEOD-5824: Transcription profiling of human Acute Lymphoblastic Leukemia CEM_C1 cells treated with rapamycin identifies rapamycin as a glucocorticoid resistance reversal agent
Experimental Factors
Phenotype Time Clinical info Dose Compound treatment
Show expression profile  /  experiment details

 
E-GEOD-3284: Transcription profiling of human leukocytes after an inflammatory stimulus (bacterial endotoxin) to identify significant functional modules perturbed in response to this stimulus using network analysis
Experimental Factors
Time Individual Compound treatment
Show expression profile  /  experiment details

 
Processing time: 0.131 secs.